Target intelligence / Profile preview

GABA transporter 1 (also known as γ-Aminobutyric Acid Transporter 1) (GAT1 (SLC6A1))

Target
GAT1 (SLC6A1)
Molecular classification
Transporter (Sodium- and chloride-dependent neurotransmitter transporter)
01

Overview

The GABA transporter 1, encoded by the SLC6A1 gene, is responsible for the sodium- and chloride-dependent reuptake of γ-aminobutyric acid (GABA) from the synaptic cleft into neurons and astrocytes. This process is crucial for terminating GABAergic neurotransmission and maintaining the balance between excitation and inhibition in neural circuits. Mutations in SLC6A1 can lead to neurodevelopmental disorders, including epilepsy and intellectual disability, due to impaired GABA transport and disrupted neurotransmitter homeostasis.

Other names
GABA transporter 1GAT1SLC6A1
02

Mechanism of action

The primary mechanism for drugs targeting SLC6A1 would involve modulation of GABA reuptake, potentially through pharmacochaperoning to correct misfolded proteins.

03

Biological functions

Neurotransmitter reuptaketermination of neurotransmissionregulation of synaptic GABA levels
04

Disease associations

EpilepsyNeurodevelopmental disordersAutism spectrum disorderIntellectual disability
05

Safety considerations

Disruption of GABAergic neurotransmission can lead to severe neurological symptoms, such as seizures and intellectual disability.
06

Interacting drugs

glycerol

1 more in the full profile.

07

Biomarkers

Genetic mutations in SLC6A1

Beyond the preview

Go deeper on GABA transporter 1 (also known as γ-Aminobutyric Acid Transporter 1) (GAT1 (SLC6A1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GABA transporter 1 (also known as γ-Aminobutyric Acid Transporter 1) (GAT1 (SLC6A1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call